The Accuracy of Ultrasound Diagnosis of Hydatidiform Moles

Launched by KING'S COLLEGE HOSPITAL NHS TRUST · Aug 23, 2022

Keywords

ClinConnect Summary

This clinical trial is studying how well ultrasound can help doctors determine if a woman has a hydatidiform mole, which is a type of abnormal pregnancy that can happen during the first trimester. The main goal is to find out which ultrasound signs are most effective at ruling out this condition when a woman is experiencing a miscarriage. Currently, the trial is active but not recruiting new participants.

To be eligible for this study, women need to be less than 16 weeks pregnant and have a single pregnancy. They should have an ultrasound that suggests either an early loss of the embryo or a possible molar pregnancy. Women who are expecting twins, have an ectopic pregnancy (where the pregnancy is outside the uterus), or are unable to understand English well enough to participate cannot join the study. Participants can expect to undergo ultrasound scans and will help researchers understand how these scans can improve diagnosis and care for women experiencing early pregnancy complications.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • less than 16 weeks gestation by last menstrual period or by ultrasound
• • singleton pregnancy
• • ultrasound diagnosis of early embryonic demise or incomplete miscarriage or suspected molar pregnancy.
• Exclusion Criteria:
• • Women declining participation and follow up
• • Women who refuse transvaginal scan
• • Multiple pregnancy
• • Ectopic pregnancy
• • Pregnancy of unknown location
• • Those unable to understand English to an adequate degree to understand and consent to participation in this study